SCHEMBL7225949

SCHEMBL7225949

Nc1ccccc1Oc1ccc(C(=O)N[C@@H]2C[C@H]3CC[C@@H]2N3)s1

nearest known ligand 0.35

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 5/20 0.35
HTR3E A5X5Y0 4/20 0.33
HTR3B O95264 4/20 0.33
HTR3A P46098 4/20 0.33
HTR3D Q70Z44 4/20 0.33
HTR3C Q8WXA8 4/20 0.33
SLC6A3 Q01959 3/20 0.31
HTR4 Q13639 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7224194 0.89 CHRNA7 (0.35) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7222652 0.88 CTNNB1 (0.36) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7225513 0.88 CHRNA7 (0.37) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7229885 0.88 SLC6A4 (0.39) CHRNA7SLC6A3SLC6A2SLC6A4
SCHEMBL7223853 0.88 CHRNA7 (0.43) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7230631 0.86 CHRNA7 (0.33) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7232823 0.86 EPHX2 (0.36) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7223834 0.86 KCNH2 (0.42) CHRNA7
SCHEMBL7232302 0.86 CHRNA7 (0.36) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7225638 0.85 SMN1; SMN2 (0.36) CHRNA7HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US claimed
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed